Patents by Inventor Robert Kester

Robert Kester has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SEAT MOUNTING CLIP SYSTEM
    Publication number: 20230397730
    Abstract: A seat assembly including a frame and a seat mounted to the frame via one or more clips. In one example, the clips include a lock assembly configured to extend through an opening in a seat support. The lock assembly includes a T-lock with one or more tabs configured to lock the clip within the opening without the use of tools and/or other fasteners. In another example, the lock assembly is inserted into the opening and the clip is rotated 90 degrees from an unlocked to a locked position. In yet another example, the clip includes a retention assembly with a snap button configured to snap-fit within an aperture to prevent accidental rotation and/or removal of the clip from the opening.
    Type: Application
    Filed: August 25, 2023
    Publication date: December 14, 2023
    Applicant: Indiana Mills & Manufacturing, Inc.
    Inventors: Kegan McKinney Crawford, Jonathan Austin DuBois, Robert A. Kester, JR.
  • 2-oxo-2,3,4,5-tetrahydro-1 H-benzo[B]diazepines and their use in the treatment of cancer
    Patent number: 9422331
    Abstract: Disclosed are compounds of Formula I or pharmaceutically acceptable salts thereof, wherein W, Y, Z, R1, R2, R3, R4 and R5 are described herein, and methods of using said compounds in the treatment of cancer.
    Type: Grant
    Filed: September 16, 2013
    Date of Patent: August 23, 2016
    Assignee: HOFFMANN-LA ROCHE INC.
    Inventors: Andrew Forrest Donnell, Robert Kester, Yan Lou, John Anthony, Stacy Remiszewski
  • 2-OXO-2,3,4,5-TETRAHYDRO-1 H-BENZO[B]DIAZEPINES AND THEIR USE IN THE TREATMENT OF CANCER
    Publication number: 20150225449
    Abstract: Disclosed are compounds of Formula I or pharmaceutically acceptable salts thereof, wherein W, Y, Z, R1, R2, R3, R4 and R5 are described herein, and methods of using said compounds in the treatment of cancer.
    Type: Application
    Filed: September 16, 2013
    Publication date: August 13, 2015
    Inventors: Andrew Forrest Donnell, Robert Kester, Yan Lou, John Anthony, Stacy Remiszewski
  • Heteroaromatic glucokinase activators
    Publication number: 20070203207
    Abstract: 2,3-Di-substituted N-heteroaromatic propionamides with said substitution at the 3-position being a substituted phenyl group and at the 2-position being a methyl cycloalkyl ring, said propionamides being glucokinase activators which increase insulin secretion in the treatment of type II diabetes.
    Type: Application
    Filed: April 23, 2007
    Publication date: August 30, 2007
    Inventors: Fred Bizzarro, Wendy Corbett, Joseph Grippo, Nancy-Ellen Haynes, George Holland, Robert Kester, Paige Mahaney, Ramakanth Sarabu
  • MCH receptor antagonists
    Publication number: 20070078165
    Abstract: Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of obesity, hyperphagia, anxiety, depression and related disorders and diseases.
    Type: Application
    Filed: September 25, 2006
    Publication date: April 5, 2007
    Inventors: Steven Berthel, Shawn Erickson, Nader Fotouhi, Robert Kester, Kyungjin Kim, Steven Mischke, Yimin Qian, Kshitij Thakkar, Jefferson Tilley, Hong Wang
  • Substituted-cycloalkyl and oxygenated-cycloalkyl glucokinase activators
    Publication number: 20060178429
    Abstract: 2,3-Di-substituted N-heteroaromatic propionamides with said substitution at the 2-position being a substituted phenyl group and at the 3-position being a polar ring, said propionamides being glucokinase activators which increase insulin secretion in the treatment of type II diabetes.
    Type: Application
    Filed: April 10, 2006
    Publication date: August 10, 2006
    Inventors: Wendy Corbett, Joseph Grimsby, Nancy-Ellen Haynes, Robert Kester, Paige Mahaney, Jagdish Racha, Ramakanth Sarabu, Ka Wang
  • Heteroaromatic glucokinase activators
    Publication number: 20050261503
    Abstract: 2,3-Di-substituted N-heteroaromatic propionamides with said substitution at the 3-position being a substituted phenyl group and at the 2-position being a methyl cycloalkyl ring, said propionamides being glucokinase activators which increase insulin secretion in the treatment of type II diabetes.
    Type: Application
    Filed: April 4, 2005
    Publication date: November 24, 2005
    Inventors: Fred Bizzaro, Wendy Corbett, Joseph Grippo, Nancy-Ellen Haynes, George Holland, Robert Kester, Paige Mahaney, Ramakanth Sarabu